Chiron Dealt Blow Over Cystic Fibrosis Treatment
The patent at issue in the case, U.S. Patent No. 6,890,907, covers a method of treating lung infections by using certain concentrations of liquid tobramycin with high-efficiency nebulizers.
The method is aimed at treating patients suffering from cystic fibrosis, a debilitating disease that manifests in early childhood...
To view the full article, register now.